Four decades of HIV/AIDS - much accomplished, much to do

Fauci, Anthony S.; Lane, H. Clifford

doi:10.1056/nejmp1916753

Cited by 206HIV/AIDS Research and InterventionsHIV, Drug Use, Sexual RiskHIV Research and Treatment

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Four decades of HIV/AIDS - much accomplished, much to do

Fauci, Anthony S., Lane, H. Clifford·2020·New England Journal of Medicine

DOI 10.1056/nejmp1916753

Open this paper in CoChat — free account

Abstract

Four Decades of HIV/AIDS Considering the spectacular scientific advances that have been made over nearly four decades, it is conceivable that with optimal implementation of available prevention str...

Integrity signals

Registry

Crossref · 10.1056/nejmp1916753

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Increasing treatment coverage and preventive strategies, particularly advances in antiretroviral therapy and the implementation of treatment-as-prevention programmes, reduced HIV/AIDS burden globally in 2021.
“Increasing treatment coverage and preventive strategies, particularly advances in antiretroviral therapy and the implementation of treatment-as-prevention programmes,31 reduced HIV/AIDS burden globally in 2021.”
From Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 (2024) · cites this paper as [31]

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)
Barré-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., et al. (1983) · Science · doi:10.1126/science.6189183 · Cited by 7,038
Prevention of HIV-1 infection with early antiretroviral therapy.
Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105243 · Cited by 6,873
Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS
Gallo, R. C., Salahuddin, S. Z., Popovič, M., Shearer, G. M., Kaplan, M., Haynes, B. F., Palker, T. J., Redfield, R. R., Oleske, J. M., Safai, B., et al. (1984) · Science · doi:10.1126/science.6200936 · Cited by 3,639
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
Gulick, R. M., Mellors, J. W., Havlir, D. V., Eron, J. J., Gonzalez, C. J., McMahon, D. K., Richman, D. D., Valentine, F. T., Jonas, L., Meibohm, A. R., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371102 · Cited by 1,883
An Outbreak of Community-AcquiredPneumocystis cariniiPneumonia
Masur, H., Michelis, M. A., Greene, J. B., Onorato, I. M., Stouwe, R. A. V., Holzman, R. S., Wormser, G. P., Brettman, L. R., Lange, M., Murray, H. W., et al. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112103052402 · Cited by 1,434

Flagged first, then by citations

Sorted by citations

Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
Ferrari, A. J., Santomauro, D. F., Aali, A., Abate, Y. H., Abbafati, C., Abbastabar, H., Abd ElHafeez, S., Abdelmasseh, M., Abd-Elsalam, S., Abdollahi, A., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00757-8 · Cited by 5,112
COVID-19 vaccines: rapid development, implications, challenges and future prospects
Kashte, S., Gulbake, A., El‐Amin, S. F., & Gupta, A. (2021) · Human Cell · doi:10.1007/s13577-021-00512-4 · Cited by 426
Impact of national lockdown towards emergency department visits and admission rates during the COVID ‐19 pandemic in Thailand: A hospital‐based study
Wongtanasarasin, W., Srisawang, T., Yothiya, W., & Phinyo, P. (2020) · Emergency Medicine Australasia · doi:10.1111/1742-6723.13666 · Cited by 76
Contemporary Medicinal Chemistry Strategies for the Discovery and Development of Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors
Wang, Z., Cherukupalli, S., Xie, M., Wang, W., Jiang, X., Jia, R., Pannecouque, C. C., Clercq, E. D., Kang, D., Zhan, P., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01758 · Cited by 75
Hydroxychloroquine and COVID-19: a Rheumatologist’s Take on the Lessons Learned
Udupa, A., Leverenz, D. L., Balevic, S. J., Sadun, R. E., Tarrant, T. K., & Rogers, J. L. (2021) · Current Allergy and Asthma Reports · doi:10.1007/s11882-020-00983-9 · Cited by 108
Law, criminalisation and HIV in the world: have countries that criminalise achieved more or less successful pandemic response?
Kavanagh, M. M., Agbla, S. C., Pillinger, M., Joy, M., Case, A., Erondu, N. A., Aneja, K., Erkkola, T., & Graeden, E. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2021-006315 · Cited by 69
A Geography of Risk: Structural Racism and Coronavirus Disease 2019 Mortality in the United States
Zalla, L. C., Martin, C. L., Edwards, J. K., Gartner, D. R., & Noppert, G. A. (2021) · American Journal of Epidemiology · doi:10.1093/aje/kwab059 · Cited by 66
Weight Gain After HIV Therapy Initiation: Pathophysiology and Implications
Chandiwana, N. C., Siedner, M. J., Marconi, V. C., Hill, A. M., Ali, M. K., Batterham, R. L., & Venter, F. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad411 · Cited by 62
Directing Research Toward Health Equity: a Health Equity Research Impact Assessment
Castillo, E. G., & Harris, C. (2021) · Journal of General Internal Medicine · doi:10.1007/s11606-021-06789-3 · Cited by 52
People who living with HIV/AIDS also have a high prevalence of anxiety disorders: a systematic review and meta-analysis
Ji, J., Zhang, Y., Ma, Y., Jia, L., Cai, M., Li, Z., Zhang, T., & Guo, C. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1259290 · Cited by 51
Treatment of out-of-hospital cardiac arrest in the COVID-19 era: A 100 days experience from the Lombardy region
Baldi, E., Sechi, G. M., Mare, C., Canevari, F., Brancaglione, A., Primi, R., Palo, A., Contri, E., Ronchi, V., Beretta, G., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241028 · Cited by 47
Can SARS‐CoV‐2 vaccine increase the risk of reactivation of Varicella zoster? A systematic review
Desai, H. D., Sharma, K. H., Shah, A., Patoliya, J., Patil, A. D., Hooshanginezhad, Z., Grabbe, S., & Goldust, M. (2021) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.14521 · Cited by 50
Lack of dyspnea in patients with Covid‐19: another neurological conundrum?
Recasens, B. B., Martínez‐Llorens, J., Rodríguez‐Sevilla, J. J., & Rubio, M. Á. (2020) · European Journal of Neurology · doi:10.1111/ene.14265 · Cited by 46
Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trial
Houser, K. V., Gaudinski, M. R., Happe, M., Narpala, S., Verardi, R., Sarfo, E. K., Corrigan, A. R., Wu, R., Rothwell, R. S., Novik, L., et al. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101477 · Cited by 42
Continued need for non-pharmaceutical interventions after COVID-19 vaccination in long-term-care facilities
Love, J., Keegan, L. T., Angulo, F. J., McLaughlin, J. M., Shea, K. M., Swerdlow, D. L., Samore, M. H., & Toth, D. J. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-97612-w · Cited by 40
Current Status of HIV-1 Vaccines
Hargrave, A., Mustafa, A. S., Hanif, A., Tunio, J. H., & Hanif, S. N. M. (2021) · Vaccines · doi:10.3390/vaccines9091026 · Cited by 41
Highly Attenuated Poxvirus-Based Vaccines Against Emerging Viral Diseases
Perdiguero, B., Pérez, P., Marcos-Villar, L., Albericio, G., Astorgano, D., Álvarez, E., Sin, L., Gómez, C. E., García‐Arriaza, J., & Estéban, M. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168173 · Cited by 39
Strengthening immunity through healthy lifestyle practices: Recommendations for lifestyle interventions in the management of COVID‐19
Monye, I. N., & Adelowo, A. B. (2020) · Lifestyle Medicine · doi:10.1002/lim2.7 · Cited by 38
Voluntary Counseling and Testing, Antiretroviral Therapy Access, and HIV-Related Stigma: Global Progress and Challenges
Armstrong-Mensah, E. A., Tetteh, A. K., Ofori, E., & Ekhosuehi, O. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19116597 · Cited by 37
Out-of-hospital cardiac arrests and mortality in Swiss Cantons with high and low COVID-19 incidence: A nationwide analysis
Baldi, E., Auricchio, A., Klersy, C., Burkart, R., Benvenuti, C., Vanetta, C., & Bärtschi, J. (2021) · Resuscitation Plus · doi:10.1016/j.resplu.2021.100105 · Cited by 36
RNA-Targeting Splicing Modifiers: Drug Development and Screening Assays
Tang, Z., Zhao, J., Pearson, Z., Bošković, Ž., & Wang, J. (2021) · Molecules · doi:10.3390/molecules26082263 · Cited by 36
Lesbian, Gay, Bisexual, Transgender, and Queer (LGBTQ+) Communities and the Coronavirus Disease 2019 Pandemic: A Call to Break the Cycle of Structural Barriers
Gil, R. M., Freeman, T. L., Mathew, T. A., Kullar, R., Fekete, T., Ovalle, A. A., Nguyen, D., Kottkamp, A. C., Poon, J., Marcelin, J. R., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab392 · Cited by 37
SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic
Schoenhals, M. J., Rabenindrina, N., Rakotondramanga, J. M., Dussart, P., Randremanana, R. V., Héraud, J., Andriamandimby, S. F., Sahondranirina, P. H., Vololoniaina, M. C., Randriatsarafara, F. M., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103419 · Cited by 34
Advanced HIV Infection in Treatment-Naïve Individuals: Effectiveness and Persistence of Recommended 3-Drug Regimens
Mounzer, K., Brunet, L., Fusco, J. S., McNicholl, I. R., Díaz-Cuervo, H., Sension, M., McCurdy, L., & Fusco, G. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac018 · Cited by 35
Thymic Exhaustion and Increased Immune Activation Are the Main Mechanisms Involved in Impaired Immunological Recovery of HIV-Positive Patients under ART
Guedes, M. C. S., Carvalho‐Silva, W. H. V., Andrade‐Santos, J. L., de Castro, M. C. A. B., Souto, F. O., & Guimarães, R. L. (2023) · Viruses · doi:10.3390/v15020440 · Cited by 34
Adjunct Therapy for CD4+ T-Cell Recovery, Inflammation and Immune Activation in People Living With HIV: A Systematic Review and Meta-Analysis
Zhang, Y., Jiang, T., Li, A., Li, Z., Hou, J., Gao, M., Huang, X., Su, B., Wu, H., Zhang, T., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.632119 · Cited by 32
Long-term trends of HIV/AIDS incidence in India: an application of joinpoint and age–period–cohort analyses: a gendered perspective
Shri, N., Bhattacharyya, K., Dhamnetiya, D., Singh, M., Jha, R. P., & Patel, P. D. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1093310 · Cited by 30
Roles, Characteristics, and Analysis of Intrinsically Disordered Proteins: A Minireview
Lermyte, F. (2020) · Life · doi:10.3390/life10120320 · Cited by 32
Discovery of Novel Dihydrothiopyrano[4,3- d ]pyrimidine Derivatives as Potent HIV-1 NNRTIs with Significantly Reduced hERG Inhibitory Activity and Improved Resistance Profiles
Wang, Z., Zalloum, W. A., Wang, W., Jiang, X., Clercq, E. D., Pannecouque, C. C., Kang, D., Zhan, P., & Liu, X. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01015 · Cited by 28
Capacity and Readiness Assessment of Healthcare Facilities for Digital Health Interventions Against Tuberculosis and HIV in Addis Ababa, Ethiopia
Getachew, E., Woldeamanuel, Y., & Manyazewal, T. (2022) · Frontiers in Digital Health · doi:10.3389/fdgth.2022.821390 · Cited by 27
Stochastic global exponential stability of disease-free equilibrium of HIV/AIDS model
El-Metwally, H. A., Sohaly, M. A., & Elbaz, I. M. (2020) · The European Physical Journal Plus · doi:10.1140/epjp/s13360-020-00856-0 · Cited by 27
Development of Novel Dihydrofuro[3,4- d ]pyrimidine Derivatives as HIV-1 NNRTIs to Overcome the Highly Resistant Mutant Strains F227L/V106A and K103N/Y181C
Kang, D., Sun, Y., Feng, D., Gao, S., Wang, Z., Jing, L., Zhang, T., Jiang, X., Lin, H., Clercq, E. D., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01885 · Cited by 27
People Living with HIV and AIDS: Experiences towards Antiretroviral Therapy, Paradigm Changes, Coping, Stigma, and Discrimination—A Grounded Theory Study
Beichler, H., Kutalek, R., & Dorner, T. E. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20043000 · Cited by 25
Comprehensive HIV/AIDS knowledge and HIV testing among men in sub-Saharan Africa: a multilevel modelling
Tetteh, J. K., Frimpong, J. B., Budu, E., Adu, C., Mohammed, A., Ahinkorah, B. O., & Seidu, A. (2021) · Journal of Biosocial Science · doi:10.1017/s0021932021000560 · Cited by 27
Escaping from Flatland: Multiparameter Optimization Leads to the Discovery of Novel Tetrahydropyrido[4,3-d]pyrimidine Derivatives as Human Immunodeficiency Virus-1 Non-nucleoside Reverse Transcriptase Inhibitors with Superior Antiviral Activities against Non-nucleoside Reverse Transcriptase Inhibitor-Resistant Variants and Favorable Drug-like Profiles
Wang, Z., Sharma, P. P., Rathi, B., Xie, M., Clercq, E. D., Pannecouque, C. C., Kang, D., Zhan, P., & Liu, X. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00275 · Cited by 25
Pre-Exposure Prophylaxis Barriers, Facilitators and Unmet Need Among Rural People Who Inject Drugs: A Qualitative Examination of Syringe Service Program Client Perspectives
Surratt, H. L., Yeager, H., Adu, A. K., González, E. A., Nelson, E. O., & Walker, T. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.905314 · Cited by 22
How to properly define immunological nonresponse to antiretroviral therapy in people living with HIV? an integrative review
Guedes, M. C. S., Lopes‐Araujo, H. F., dos Santos, K. F., Simões, E., Carvalho‐Silva, W. H. V., & Guimarães, R. L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1535565 · Cited by 21
Does Angiotensin II Peak in Response to SARS-CoV-2?
Xavier, L. L., Neves, P. F. R., Paz, L. V., Neves, L. T., Bagatini, P. B., Timmers, L. F. S. M., Rasia‐Filho, A. A., Mestriner, R. G., & Wieck, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.577875 · Cited by 21
Mental health and quality of life for people with rheumatoid arthritis or ankylosing spondylitis in Aotearoa New Zealand following the COVID-19 national lockdown
Johnstone, G., Treharne, G. J., Fletcher, B. D., Lamar, R. S. M., White, D., Harrison, A. A., & Stebbings, S. M. (2021) · Rheumatology International · doi:10.1007/s00296-021-04952-x · Cited by 22
Structure-Directed Expansion of Biphenyl-Pyridone Derivatives as Potent Non-Nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Potency and Safety
Zhao, L., Pannecouque, C. C., Clercq, E. D., Wang, S., & Chen, F. (2022) · Chinese Chemical Letters · doi:10.1016/j.cclet.2023.108261 · Cited by 20
In situ click chemistry-based discovery of 1,2,3-triazole-derived diarylpyrimidines as novel HIV-1 NNRTIs by exploiting the tolerant region I in binding pocket
Sun, Y., Feng, D., Zhou, Z., Zhang, T., Clercq, E. D., Pannecouque, C. C., Kang, D., Zhan, P., & Liu, X. (2023) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2023.117484 · Cited by 20
The economic impact of pharmacist care for people living with HIV/AIDS: A systematic review
Ahmed, A., Dujaili, J. A., Hashmi, F. K., Awaisu, A., Chaiyakunapruk, N., & Hasan, S. S. (2021) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2021.100066 · Cited by 19
Lead Optimization and Avoidance of Metabolic-perturbing Motif Developing Novel Diarylpyrimidines as Potent HIV-1 NNRTIs
Sun, Y., Zhou, Z., Feng, D., Jing, L., Zhao, F., Wang, Z., Zhang, T., Lin, H., Song, H., Clercq, E. D., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00576 · Cited by 18
An update on neuropsychiatric adverse effects with second-generation integrase inhibitors and nonnucleoside reverse transcriptase inhibitors
Senneker, T., & Tseng, A. L.-I. (2021) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000705 · Cited by 18
Seroprevalence and risk factors for SARS-CoV-2 Infection in selected urban areas in Ethiopia: a cross-sectional evaluation during July 2020
Tadese, E. B., Endris, A. A., Solomon, H., Alayu, M., Kebede, A., Eshetu, K., Teka, G., Eskinder, B., Ahmed, J., Abayneh, S., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.08.028 · Cited by 16
Changes in proportionate cardiovascular mortality in patients with chronic infectious and inflammatory conditions in the United States, 1999–2018
Groenendyk, J., Rivera, A. S., Sinha, A., Lloyd‐Jones, D. M., & Feinstein, M. J. (2021) · Scientific Reports · doi:10.1038/s41598-021-03407-4 · Cited by 16
HIV-associated neurocognitive disorders (HAND): Optimal diagnosis, antiviral therapy, pharmacological treatment, management, and future scopes
Adhikary, K., Banerjee, A., Sarkar, R., Banerjee, R., Chowdhury, S. R., Ganguly, K., & Karak, P. (2025) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2025.123410 · Cited by 20
Sirtuins as Interesting Players in the Course of HIV Infection and Comorbidities
Jurkowska, K., Szymańska, B., Knysz, B., Kuźniarski, A., & Piwowar, A. (2021) · Cells · doi:10.3390/cells10102739 · Cited by 16
The 1918–20 Influenza Pandemic
Athukorala, P., & Athukorala, C. (2022) · Cambridge University Press eBooks · doi:10.1017/9781009336062 · Cited by 16
Liver Transplantation for HCC in HIV-Infected Patients: Long-Term Single-Center Experience
Guerrini, G. P., Berretta, M., Guaraldi, G., Magistri, P., Esposito, G., Ballarin, R., Serra, V., Sandro, S. D., & Benedetto, F. D. (2021) · Cancers · doi:10.3390/cancers13184727 · Cited by 15
Structure-based design and optimization lead to the identification of novel dihydrothiopyrano[3,2-d]pyrimidine derivatives as potent HIV-1 inhibitors against drug-resistant variants
Wang, Z., Zhang, H., Gao, Z., Sang, Z., Clercq, E. D., Pannecouque, C. C., Kang, D., Zhan, P., & Liu, X. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.11.023 · Cited by 15
Mental health progress requires causal diagnostic nosology and scalable causal discovery
Saxe, G., Bickman, L., Ma, S., & Aliferis, C. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.898789 · Cited by 13
Frequency of fungal pathogens in autopsy studies of people who died with HIV in Africa: a scoping review
Bongomin, F., Kibone, W., Atulinda, L., Morgan, B., Ocansey, B. K., Storer, I. S. R., van Rhijn, N., Muzoora, C. K., Denning, D. W., & Hamer, D. H. (2023) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2023.12.016 · Cited by 13
Psychosocial and mental health challenges facing perinatally HIV-infected adolescents along the Kenyan coast: a qualitative inquiry using the socioecological model
Wanjala, S. W., Nyongesa, M. K., Luchters, S. M. F., & Abubakar, A. A. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1379262 · Cited by 13
Toward Personalized Medicine for HIV/AIDS
Kumbale, C. M., & Voit, E. O. (2021) · Journal of AIDS and HIV Treatment · doi:10.33696/aids.3.020 · Cited by 13
Prioritizing Mental Health within HIV and Tuberculosis Services in PEPFAR
Fukunaga, R., Pierre, P., Williams, J. K., Briceno-Robaugh, R., Kalibala, S., Peterson, M., & Moonan, P. K. (2024) · Emerging infectious diseases · doi:10.3201/eid3004.231726 · Cited by 15
Guidelines for Antibiotics Prescription in Critically Ill Patients
Chaudhry, D., Desai, M., Gupta, M., Mohan, A., Mehta, Y. B., Sengar, M., Govil, D., Hegde, A. V., Rungta, N., Mittal, S., et al. (2024) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24677 · Cited by 16
Implementation and Access to Pre-exposure Prophylaxis for Human Immunodeficiency Virus by Men Who Have Sex With Men in Europe
Sepodes, B. M. N., Rocha, J. P., Batista, J., Figueira, M. E., Dráfi, F., & Torre, C. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.722247 · Cited by 11
The challenge of dealing with non-AIDS comorbidities for people living with HIV: Perspectives and experiences of patients and healthcare providers
van Koeveringe, J. M., Callahan, E. L., George, M., Teshome, T., Seifu, B., & Spigt, M. (2023) · Global Public Health · doi:10.1080/17441692.2023.2185798 · Cited by 12
Leveraging big data for causal understanding in mental health: a research framework
Newson, J. J., Bala, J. W., Giedd, J. N., Maxwell, B., & Thiagarajan, T. C. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1337740 · Cited by 12
Advances in diarylpyrimidines and related analogues as HIV-1 nonnucleoside reverse transcriptase inhibitors (2019–2023)
Nie, M.-Z., Zhang, S., Gu, S., Long, J., & Zhu, Y. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116973 · Cited by 10
HIV Promotes Atherosclerosis via Circulating Extracellular Vesicle MicroRNAs
Ferreira, A. D. F., Wei, J., Zhang, L., Macon, C. J., Degnan, B., Jayaweera, D. T., Hare, J. M., Kolber, M. A., Bellio, M. A., Khan, A., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087567 · Cited by 10
Design, synthesis, and biological evaluation of benzo[4,5]thieno[2,3-d]pyrimidine derivatives as novel HIV-1 NNRTIs
Meng, B., Zhuo, Z., Yu, H., Tao, S., Chen, Z., Clercq, E. D., Pannecouque, C. C., Kang, D., Zhan, P., & Liu, X. (2023) · Chinese Chemical Letters · doi:10.1016/j.cclet.2023.108827 · Cited by 10
Potentially Inappropriate Prescribing in Older People Living With HIV: A Scoping Review
Vélez‐Díaz‐Pallarés, M., Delgado-Silveira, E., Fradejas, J. F., Montero-Llorente, B., Palomar-Fernández, C., Montero‐Errasquín, B., Cruz-Jentoft, A. J., & Álvarez‐Díaz, A. M. (2023) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003298 · Cited by 11
The Devastating Effects of the COVID-19 Pandemic Among Ethnic Minorities, Migrants, and Refugees
Navarro-Román, L., & Román, G. C. (2021) · Sustainable development goals series · doi:10.1007/978-3-030-81058-0_13 · Cited by 11
Added Value of Next Generation Sequencing in Characterizing the Evolution of HIV-1 Drug Resistance in Kenyan Youth
Novitsky, V., Nyandiko, W. M., Vreeman, R., DeLong, A. K., Howison, M., Manne, A., Aluoch, J., Chory, A., Sang, F., Ashimosi, C., et al. (2023) · Viruses · doi:10.3390/v15071416 · Cited by 9
Vpr driving DNA methylation variation of CD4 + T cells in HIV-1 infection
Wang, P., Meng, Z., Deng, K., Gao, Z., & Cai, J. (2024) · Virology Journal · doi:10.1186/s12985-024-02363-5 · Cited by 9
The Great Influenza Pandemic of 1918–20: An interpretative survey in the time of COVID-19
Athukorala, P., & Athukorala, C. (2020) · Working Paper Series · doi:10.35188/unu-wider/2020/881-8 · Cited by 9
Design and optimization of piperidine-substituted thiophene[3,2-d]pyrimidine-based HIV-1 NNRTIs with improved drug resistance and pharmacokinetic profiles
Sun, Y., Zhou, Z., Shi, Z., Zhao, F., Xie, M., Zhuo, Z., Clercq, E. D., Pannecouque, C. C., Kang, D., Zhan, P., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.03.021 · Cited by 8
Gender and Age Trends in HIV Incidence in Turkey between 1990 and 2021: Joinpoint and Age–Period–Cohort Analyses
Derin, O. (2024) · Medicina · doi:10.3390/medicina60081357 · Cited by 8
Patient voluntarily delays call to emergency medical system for ST-elevation myocardial infarction during COVID-19 pandemic
Baldi, E., Auricchio, A., Cresta, R., Vanetta, C., Anselmi, L., Pedrazzini, G. B., & Benvenuti, C. (2021) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2021.100824 · Cited by 8
Evaluating an app-guided self-test for influenza: lessons learned for improving the feasibility of study designs to evaluate self-tests for respiratory viruses
Suchsland, M. Z., Rahmatullah, I., Lutz, B. R., Lyon, V., Huang, S., Kline, E. C., Graham, C., Cooper, S., Su, P., Smedinghoff, S., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06314-1 · Cited by 8
Roadmap for Achieving Universal Antiretroviral Treatment
Sokhela, S. M., Lalla‐Edward, S. T., Siedner, M. J., Majam, M., & Venter, F. (2023) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-052020-094321 · Cited by 9
Pathological proliferation: a potential mechanism for poor CD4+ T cell recovery in people living with HIV
Zhang, Y., Ji, J., Xie, K., Cai, M., Wang, R., Zhang, X., Chen, X., Zhang, Y., Wu, H., Wang, W., et al. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1344778 · Cited by 9
Development of enhanced HIV-1 non-nucleoside reverse transcriptase inhibitors with improved resistance and pharmacokinetic profiles
Wang, Z., Rumrill, S., Kang, D., Guma, S. D., Feng, D., De Clercq, E., Pannecouque, C., Chen, C. H., Arnold, E., Ruiz, F. X., et al. (2025) · Science Advances · doi:10.1126/sciadv.adt8916 · Cited by 7
Comparison of the Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
Bitar, Y. D. S. L., Durães, A. R., Roever, L., Neto, M. G., Lins-Kusterer, L., & Bocchi, E. A. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.712585 · Cited by 8
The Educational, Health, and Economic Impacts of COVID-19 Among Haitians in the USA: Time for Systemic Change
Seme, J., Bivins, B. L., Sternberg, C. A., Barnett, J., Junis-Florian, T., Nicolas, G., Etienne, M. O., & Jean, P. (2021) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-021-01156-8 · Cited by 7
Incorporating Within-Host Diversity in Phylogenetic Analyses for Detecting Clusters of New HIV Diagnoses
Guang, A., Howison, M., Ledingham, L., D’Antuono, M., Chan, P. A., Lawrence, C. E., Dunn, C. W., & Kantor, R. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.803190 · Cited by 7
Identification of Boronate-Containing Diarylpyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
Feng, D., Lin, H., Jiang, L., Wang, Z., Sun, Y., Zhou, Z., Clercq, E. D., Pannecouque, C. C., Kang, D., Zhan, P., et al. (2022) · Molecules · doi:10.3390/molecules27217538 · Cited by 7
A Broad-Spectrum Antiviral Molecule, Protoporphyrin IX, Acts as a Moderator of HIV-1 Capsid Assembly by Targeting the Capsid Hexamer
Zhang, D., Xie, L., Xu, X., Li, Y., & Xu, X. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02663-22 · Cited by 6
A Mathematical Model for the Co-infection Dynamics of Pneumocystis Pneumonia and HIV/AIDS with Treatment
Byamukama, M., Kajunguri, D., & Karuhanga, M. (2024) · Science Journal of Applied Mathematics and Statistics · doi:10.11648/j.sjams.20241204.11 · Cited by 6
Global, regional, and national burdens of HIV/AIDS acquired through sexual transmission 1990–2019: an observational study
Wu, X., Zhou, X., Chen, Y., Lin, Y., Li, Y., Fu, L., Liu, Q., & Zou, H. (2024) · Sexual Health · doi:10.1071/sh24056 · Cited by 7
Structure-Based Discovery and Characterization of a Preclinical Drug Candidate for the Treatment of HIV-1 Infection
Kang, D., Yang, J., Kong, L., Luo, R., Huang, X., Zhang, T., Ma, M., Feng, D., Wang, Z., Fang, H., et al. (2022) · Viruses · doi:10.3390/v14112390 · Cited by 7
Vulnerable Groups and Travel Health Considerations
McGuinness, S. L., & Steffen, R. J. (2021) · Springer eBooks · doi:10.1007/978-981-16-5415-2_4 · Cited by 6
Resource Utilization and Caring Cost of People Living with Human Immunodeficiency Virus (PLHIV) in Saudi Arabia: A Tertiary Care University Hospital Experience
Barry, M. A., Ghonem, L., Al-Beeshi, N. Z., Alrabiah, M., Alsharidi, A., & Al‐Omar, H. A. (2022) · Healthcare · doi:10.3390/healthcare10010118 · Cited by 5
Antiretroviral Therapy Coverage, Entrepreneurship, and Development in Low- and Middle-Income Countries
Rietveld, C. A., & Patel, P. C. (2024) · Business & Society · doi:10.1177/00076503241232070 · Cited by 5
Identification of novel diarylpyrimidine derivatives as potent HIV-1 non-nucleoside reverse transcriptase inhibitors against wild-type and K103N mutant viruses
Jiang, X., Zalloum, W. A., Gao, Z., Dai, J., Ji, X., Xie, M., Dong, G., Clercq, E. D., Huang, B., Pannecouque, C. C., et al. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116941 · Cited by 5
Sustained virologic suppression of multidrug-resistant HIV in an individual treated with anti-CD4 domain 1 antibody and lenacapavir
Rai, M. A., Blažková, J., Kardava, L., Justement, J. S., Shi, V., Manning, M. R., Shahid, A., Dong, W. W. Y., Kennedy, B. D., Sewack, A. B., et al. (2025) · Nature Medicine · doi:10.1038/s41591-024-03357-0 · Cited by 5
Genitourinary Infections Related to Circumcision and the Potential Impact on Male Infertility
Punjani, N., Basourakos, S. P., Nang, Q., Lee, R. K., Goldstein, M., Alukal, J. P., & Li, P. S. (2021) · The World Journal of Men s Health · doi:10.5534/wjmh.210043 · Cited by 9
Barriers associated with emergency medical service activation in patients with ST-segment elevation acute coronary syndromes
Baldi, E., Camporotondo, R., Gnecchi, M., Totaro, R., Guida, S., Costantino, I., Repetto, A., Savastano, S., Sacchi, M. C., Bollato, C., et al. (2021) · Internal and Emergency Medicine · doi:10.1007/s11739-021-02894-7 · Cited by 5
The Case for Studying New Viruses of New Hosts
Stenglein, M. D. (2022) · Annual Review of Virology · doi:10.1146/annurev-virology-100220-112915 · Cited by 5
Wenshen Jianpi recipe induced immune reconstruction and redistribution of natural killer cell subsets in immunological non-responders of human immunodeficiency virus/acquired immune deficiency syndrome: a randomized controlled trial.
Tao, Z., Wang, J., Chen, X., Yonghong, L. I., Yuguang, Y., Zhang, A., Zou, W., & Ying, L. (2022) · PubMed Central · doi:10.19852/j.cnki.jtcm.20220519.005 · Cited by 5
Update on the management of patients with HIV infection in anaesthesia and critical care
Burtle, D., Marsh, S., & Matin, N. (2023) · BJA Education · doi:10.1016/j.bjae.2023.03.004 · Cited by 5
Inferring HIV transmission patterns from viral deep-sequence data via latent typed point processes
Bu, F., Kagaayi, J., Grabowski, M. K., Ratmann, O., & Xu, J. (2024) · Biometrics · doi:10.1093/biomtc/ujad015 · Cited by 10
CAR-T Therapy in HIV: Pioneering Advances and Navigating Challenges
Wang, X., Liu, J., Hao, F., Ajavavarakula, T., & Shi, X. (2024) · Infectious Diseases & Immunity · doi:10.1097/id9.0000000000000129 · Cited by 6
Uracil derivatives as non-nucleoside inhibitors targeting HIV-1 reverse transcriptase
Chen, J. P., Yang, G., Tian, L., Zhu, Y., Zhang, S., & Gu, S. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.118797 · Cited by 4
Longitudinal trajectories of weight changes among people living with HIV on antiretroviral therapy: A group-based study
Wu, X., Zhang, L., Lu, Z., Li, Y., He, Y., Zhao, F., Peng, Q., Zhou, X., Wang, H., & Zou, H. (2023) · iScience · doi:10.1016/j.isci.2023.108259 · Cited by 3
Moving Beyond Viral Suppression: Poor Patient–Provider Communication and Its Impact on Healthcare Outcomes Among People Living With HIV in the United States
Tadese, B. K., Cambron‐Mellott, M. J., Arduino, J. M., Balkaran, B. L., Eslamimehr, S., & Zuniga, J. M. (2025) · Journal of the International Association of Providers of AIDS Care (JIAPAC) · doi:10.1177/23259582251359440 · Cited by 4
Constructions of HIV Risk Among a Diverse Sample of HIV-Negative Young Men Who Have Sex With Men Who Are Repeat Testers
Felner, J. K., Mittal, M. L., Hoenigl, M., Amico, K. R., Grelotti, D. J., Eanes, A., Hess, K., Crawford, J., & Smith, L. R. (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002614 · Cited by 4
Epidemiological investigation and proteomic profiling of typical TCM syndrome in HIV/AIDS immunological nonresponders
Ji, S., Zheng, Y., Li, X., Li, B., Zou, J., Wang, Y., Xia, X., Chen, X., Hu, Q., Wan, T., et al. (2022) · The Anatomical Record · doi:10.1002/ar.25018 · Cited by 4

Editorial: Fast-tracking HIV prevention: scientific advances and implementation challenges
Govender, K., & Poku, N. K. (2016) · African Journal of AIDS Research
Accomplishments in HIV prevention science: implications for stemming the epidemic
Valdiserri, R. O., Ogden, L. L., & McCray, E. (2003) · Nature Medicine · doi:10.1038/nm0703-881 · Cited by 66
Fast-tracking HIV prevention: scientific advances and implementation challenges
Govender, K., & Poku, N. K. (2016) · African Journal of AIDS Research · doi:10.2989/16085906.2016.1208944 · Cited by 2
HIV/AIDS in the Fourth Decade
Mugavero, M. J., & Kilby, J. M. (2017) · doi:10.1093/med/9780199392742.003.0002
The Best of Times and the Worst of Times: Implications of Scientific Advances in HIV Prevention for Women in the Developing World
Gupta, G. R. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05468.x · Cited by 2

Authors: Fauci, A. S., & Lane, H. C.
Affiliations: National Institutes of Health (US)
ORCID: Fauci, Anthony S.
Lane, H. Clifford
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2020-07-02
Volume: 383
Issue: 1
Pages: 1-4
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmp1916753
OpenAlex: W3039108403
Cited by: 199
References: 5
Citations by year: 2026: 24 · 2025: 27 · 2024: 40 · 2023: 30 · 2022: 27 · 2021: 39 · 2020: 12
FWCI: 3.64
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Keywords: HIV/AIDS, HIV prevention, HIV/AIDS research, HIV/AIDS control
MeSH terms: Acquired Immunodeficiency Syndrome, Humans, International Cooperation, Global Health, HIV Infections, Anti-Retroviral Agents, History, 20th Century, History, 21st Century, Epidemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Four decades of HIV/AIDS - much accomplished, much to do

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks